These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2899971)

  • 1. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases.
    Houston MC; Hodge R
    Am Heart J; 1988 Aug; 116(2 Pt 1):515-23. PubMed ID: 2899971
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
    Vanholder R; Lamiere N; Ringoir S
    Kidney Int Suppl; 1988 Sep; 25():S181-3. PubMed ID: 2903267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):746-61. PubMed ID: 6115528
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differential therapeutic aspects of high blood pressure therapy with beta blockers].
    Bühler FR; Bolli P
    Schweiz Rundsch Med Prax; 1983 May; 72(20):684-90. PubMed ID: 6136031
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blocker withdrawal: the song of Orpheus.
    Eichhorn EJ
    Am Heart J; 1999 Sep; 138(3 Pt 1):387-9. PubMed ID: 10467182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug information. Beta receptor blocking drugs in the treatment of hypertension. A review].
    Jensen HA; Rasmussen K
    Ugeskr Laeger; 1976 Nov; 138(47):2965-9. PubMed ID: 10660
    [No Abstract]   [Full Text] [Related]  

  • 8. Close clinical observation minimizes the complications of beta-blocker withdrawal.
    Eisele G; Gilmore LL; Blanchard EB
    Ann Pharmacother; 1994; 28(7-8):849-51. PubMed ID: 7949498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
    Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
    Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker agents: an update.
    Pas DA; Lawlor MC
    J Emerg Nurs; 1986; 12(1):18-22. PubMed ID: 2869178
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardiovascular actions of the beta-adrenoceptor antagonists.
    Ungar A
    Eur J Clin Invest; 1979 Jun; 9(3):175-7. PubMed ID: 38967
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications.
    Frishman W; Silverman R
    Am Heart J; 1979 Jul; 98(1):119-31. PubMed ID: 36741
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of withdrawal of long-term treatment with beta-adrenoceptor blocking agents in subjects with essential hypertension.
    Bengtsson C; Larsson Y; Panfilov V; Sivertsson R; Aström H
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():421s-423s. PubMed ID: 6119181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking agents.
    Prof Nurse; 2002 Jun; 17(10):591. PubMed ID: 12087706
    [No Abstract]   [Full Text] [Related]  

  • 17. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients.
    Shammash JB; Trost JC; Gold JM; Berlin JA; Golden MA; Kimmel SE
    Am Heart J; 2001 Jan; 141(1):148-53. PubMed ID: 11136500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of beta adrenergic blocking drugs in cardiovascular disease.
    Prichard BN
    Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.